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abstract
 
Neurotransmitter transporters are reported to mediate transmembrane ion movements that are
poorly coupled to neurotransmitter transport and to exhibit complex “channel-like” behaviors that challenge the
classical “alternating access” transport model. To test alternative models, and to develop an improved model for
the Na
 
1
 
- and Cl
 
2
 
-dependent 
 
g
 
-aminobutyric acid (GABA) transporter, GAT1, we expressed GAT1 in 
 
Xenopus
 
oocytes and analyzed its function in detail in giant membrane patches. We detected no Na
 
1
 
- or Cl
 
2
 
- dependent
currents in the absence of GABA, nor did we detect activating effects of substrates added to the trans side. Out-
ward GAT1 current (“reverse” transport mode) requires the presence of all three substrates on the cytoplasmic
side. Inward GAT1 current (“forward” transport mode) can be partially activated by GABA and Na
 
1
 
 on the extra-
cellular (pipette) side in the nominal absence of Cl
 
2
 
. With all three substrates on both membrane sides, reversal
potentials deﬁned with speciﬁc GAT1 inhibitors are consistent with the proposed stoichiometry of 1GABA:2Na
 
1
 
:
1Cl
 
2
 
. As predicted for the “alternating access” model, addition of a substrate to the trans side (120 mM extracellu-
lar Na
 
1
 
) decreases the half-maximal concentration for activation of current by a substrate on the cis side (cytoplas-
mic GABA). In the presence of extracellular Na
 
1
 
, the half-maximal cytoplasmic GABA concentration is increased
by decreasing cytoplasmic Cl
 
2
 
. In the absence of extracellular Na
 
1
 
, half-maximal cytoplasmic substrate concentra-
tions (8 mM Cl
 
2
 
, 2 mM GABA, 60 mM Na
 
1
 
) do not change when cosubstrate concentrations are reduced, with the
exception that reducing cytoplasmic Cl
 
2
 
 increases the half-maximal cytoplasmic Na
 
1
 
 concentration. The forward
GAT1 current (i.e., inward current with all extracellular substrates present) is inhibited monotonically by cytoplas-
mic Cl
 
2
 
 (
 
K
 
i
 
, 8 mM); cytoplasmic Na
 
1
 
 and cytoplasmic GABA are without effect in the absence of cytoplasmic Cl
 
2
 
.
In the absence of extracellular Na
 
1
 
, current–voltage relations for reverse transport current (i.e., outward current
with all cytoplasmic substrates present) can be approximated by shallow exponential functions whose slopes are
consistent with rate-limiting steps moving 0.15–0.3 equivalent charges. The slopes of current–voltage relations
change only little when current is reduced four- to eightfold by lowering each cosubstrate concentration; they in-
crease twofold upon addition of 100 mM Na
 
1
 
 to the extracellular (pipette) side.
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introduction 
 
Neurotransmitter transporters, many of which are of
great medical importance (Wong et al., 1995; Meyer et
al., 1996; Ni and Miledi, 1997), couple the “uphill”
transport of neurotransmitters into cells to the “down-
hill” movement of Na
 
1
 
. Transport is often coupled to
transmembrane movements of other ions, such as Cl
 
2
 
,
K
 
1
 
, and/or protons (Wong et al., 1995; Meyer et al.,
1996; Ni and Miledi, 1997). Two distinct gene families
for plasmalemmal neurotransmitter transporters are
identiﬁed, the family of Na
 
1
 
/Cl
 
2
 
-dependent transport-
ers for 
 
g
 
-aminobutyric acid (GABA),
 
1
 
 glycine, seroto-
nin, and catecholamines and the family of excitatory
amino acid transporters (Amara and Arriza, 1993;
Lester et al., 1994). GABA transport could be studied in
native membranes, and a transport stoichiometry of
1GABA:2Na
 
1
 
:1Cl
 
2
 
 was suggested (Radian and Kanner,
1983; Keynan and Kanner, 1988; Kanner and Schuldi-
ner, 1987). The GABA transporter, GAT1, was the ﬁrst
member of its family to be cloned (Guastella et al.,
1990), and initial ﬁndings on GAT1 expressed in 
 
Xeno-
pus
 
 oocytes (Kavanaugh et al., 1992; Mager et al., 1993)
were consistent with the proposed stoichiometry.
Stoichiometric transport of substrates is usually ex-
plained by the “alternating access” hypothesis (Jar-
detzky, 1966; Läuger, 1991), whereby conformational
changes allow substrates to bind alternatively on one
membrane side or the other, and to be transported
across the membrane (for overview of cotransport
models and references, see Jauch and Läuger, 1986).
However, recent studies have led several authors to
question the validity of the alternating access model for
GAT1: some ﬁndings suggest the existence of “leak
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modes” of the transporter (e.g., uncoupled current in
the absence of GABA) that result in major departures
from the accepted stoichiometry (Cammack et al.,
1994; Cammack and Schwartz, 1996; Galli et al., 1996;
Mager et al., 1996; Sonders and Amara, 1996). Addi-
tionally, some GABA uptake studies, in combination
with current measurements, suggest much larger Na
 
1
 
movements than predicted by a 1GABA:2Na
 
1
 
:1Cl
 
2
 
 stoi-
chiometry (Risso et al., 1996; Bechkman and Quick,
1998). Furthermore, channel-like behaviors have been
identiﬁed as current noise in some recordings and as
probable “single channel” currents under certain con-
ditions in other recordings (Cammack et al., 1994;
Galli et al., 1996). Possibly, the channel-like, nonsto-
ichiometric behaviors identiﬁed for GAT1 and other
neurotransmitter transporters, including a Cl
 
2
 
 conduc-
tance in glutamate transporters (Fairman et al., 1995),
represent important clues needed to understand the
physical basis of neurotransmitter transport (Fairman
et al., 1995; Su et al., 1996; DeFelice and Blakely, 1996).
To address these issues, we have characterized GAT1
function with the 
 
Xenopus
 
 oocyte expression system, us-
ing giant membrane patches to record GAT1 currents
(Hilgemann, 1995). For these studies, the ability to
control substrate concentrations on both membrane
sides and to voltage clamp with microsecond resolution
are major advantages of the giant patch methods
(Hilgemann and Lu, 1998). In this article, we describe
problems of measuring GAT1 currents in oocyte mem-
brane and our lack of evidence for GABA-uncoupled
currents. We characterize steady state GAT1-mediated
currents with an emphasis on the reverse (outward)
current and cis–trans substrate interactions for both
transport directions. After analyzing our results in rela-
tion to the proposed “channel-like” cotransport mod-
els, we conclude that GAT1 operates by the alternating
access principle. Thus, a major goal of our work has
been to develop an alternating-access reaction scheme
that can account for GAT1 function in 
 
Xenopus 
 
oocyte
membranes (Hilgemann and Lu, 1999).
The reaction cartoons, shown in Fig. 1, are intended
to orient the reader to our overall goal; namely, to ac-
count for the dependencies of GAT1 function on all
three substrates on both membrane sides, to account
for voltage dependencies of transport, and to account
for transporter kinetics. Fig. 1 A depicts groups of reac-
tions thought to occur in the forward transport mode
of GAT1 (i.e., moving GABA into cells) on the basis of
previous work. Perhaps the most important detail is
that a slow reaction can occlude one Na
 
1
 
 ion from the
extracellular side in the absence of GABA and chloride
(Mager et al., 1998; Hilgemann and Lu, 1999). This re-
action is electrogenic and appears to move about one
charge per transporter cycle through the membrane
electric ﬁeld. It is therefore marked with a large light-
ning symbol in Fig. 1. As further indicated, the reaction
is relatively slow (
 
t
 
 
 
5 
 
15–200 ms), and it probably rate-
limits inward current in the middle potential range,
where the slope of the current–voltage relations of the
transport current is quite steep. Evidently, GABA and
chloride can bind only after Na
 
1
 
 has been occluded by
the transporter, and when they do so, all three sub-
strates are transported to the cytoplasmic side via a
faster reaction (Fig. 1, fast) that is nearly electroneu-
tral. At large negative potentials where the “slow”
charge-moving reaction is accelerated, this “fast” trans-
location reaction probably becomes rate limiting; this
would explain the observed current saturation with hy-
perpolarization (Mager et al., 1998). It is known from
previous giant patch studies that distinct fast reactions
(
 
t
 
 
 
, 
 
1 ms) can occur in GAT1 in the absence of
substrates on both membrane sides (Lu et al., 1995).
Labeled “fast” and associated with a small lightning
symbol in Fig. 1 A, these reactions are blocked by the
presence of cytoplasmic Cl
 
2
 
, and they might represent
a reorientation of the empty transporter sites to the
outside to allow rebinding of Na
 
1
 
 (Lu et al., 1995). Pre-
sumably, these reactions never become rate limiting for
GABA transport.
The results described in this article for the reverse
transport mode (i.e., GABA transport from inside to
outside) give rise to the reaction perspectives summa-
rized in Fig. 1 B. In the absence of extracellular sub-
strates, the reverse transport cycle appears to be rate
limited by a weakly voltage-dependent reaction under
most conditions. According to our analysis, the under-
lying reaction must involve the occlusion and/or trans-
location of substrates from the cytoplasmic side. One
possible scheme is shown in Fig. 1 B, where one Cl
 
2
 
and one Na
 
1
 
 are occluded in a slow step, and all other
reactions in the reverse cycle are much faster. These in-
clude (a) the binding of a second cytoplasmic Na
 
1
 
 and
GABA, (b) electroneutral substrate transport and re-
lease to the extracellular side (Fig. 1 B, fast), (c) the
electrogenic deocclusion of Na
 
1
 
 (fast, with a large
lightning symbol), and (d) the reorientation of empty
binding sites that allows cytoplasmic Cl
 
2
 
 and Na
 
1
 
 to
bind again. We point out that the results presented in
this article alone do not justify these interpretations,
and that the interpretations alone do not allow for-
mulation of a reaction scheme for GAT1. Thus, in an
accompanying article (Lu and Hilgemann, 1999), we
describe new kinetic ﬁndings on non–steady state
GAT1 function that are critical to our interpretations.
And we describe in another article the development of
an alternating access model that can account for most
details of GAT1 function in the 
 
Xenopus
 
 oocyte mem-
brane (Hilgemann and Lu, 1999). 
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materials and methods 
 
Transporter Expression
 
GAT1 cRNA was in vitro transcribed from pBSAMVGAT1 (gift of
S. Mager, California Institute of Technology, Pasadena, CA) with
T7 polymerase and injected into 
 
Xenopus
 
 oocytes, which were iso-
lated and maintained according to Zühlke et al. (1995). Transport
currents and capacitance were recorded 4–7 d after injection in
excised giant patches. In the absence of extracellular Na
 
1
 
, out-
ward GAT1 transport current was 15–200 pA at 0 mV, depending
on patch size and expression level, in the presence of 20 mM cy-
toplasmic GABA and 120 mM cytoplasmic NaCl.
 
Electrophysiology
 
Giant inside-out oocyte membrane patches (6–12 pF; seal resis-
tance 
 
. 
 
1 G
 
V
 
) were obtained as previously described (Hilge-
mann, 1989, 1995). Methods for pipette perfusion and concen-
tration jumps are also detailed elsewhere (Hilgemann and Lu,
1998). Unless indicated otherwise, transport currents were re-
corded at 32
 
8
 
C. Membrane currents were recorded using an Axo-
patch 200 patch clamp ampliﬁer (Axon Instruments). Voltage
protocols and data acquisition were executed with Digidata 1200
(Axon Instruments), using our own software. Membrane capaci-
tance was measured according to Lu et al. (1995), using a Prince-
ton lock-in ampliﬁer (5302; EG&G Instruments). Data analysis
and curve ﬁtting used Origin5.0 (Microcal Software, Inc.).
 
Data Presentation
 
Many experiments described in this and the next article (Lu and
Hilgemann, 1999) were technically demanding. The results pre-
sented are from single experiments that we judge to be reliable.
The results were veriﬁed in multiple observations, and, usually,
two or more additional experiments with very similar results were
obtained. However, patches sometimes became unstable before
 
all data points in a protocol were acquired, and we judge that re-
sults from patches with low GAT1 expression are in general less
reliable than results from patches with high expression. For these
reasons, we do not include statistical analysis.
Current–voltage relations for the outward GAT1 currents, pre-
sented in this article, are described well by a simple exponential
(Boltzmann) function of the form, 
 
A
 
 
 
? 
 
e
 
q
 
 
 
? 
 
0.5 
 
?
 
 
 
Em
 
 
 
? 
 
F
 
/
 
RT
 
, where 
 
A
 
 is a
scalar, 
 
Em
 
 is the membrane potential, 
 
F
 
/
 
RT
 
 has its usual mean-
ing, and 
 
q
 
 is the equivalent charge. According to Eyring rate the-
ory, and assuming an energy barrier midway through the mem-
brane electrical ﬁeld, the “equivalent charge” is the amount of
charge that would have to move through the entire membrane
ﬁeld to account for the voltage dependence. This is “equivalent”
to a proportionally larger charge amount that would move
through a proportionally smaller fraction of membrane ﬁeld to
account for the same voltage dependence. 
 
RT/F 
 
was approxi-
mated as 26.5 mV.
 
Solutions
 
The standard bath solution contained (mM): 0–20 GABA, 120
NaCl, 0.5 magnesium sulfamate, 20 tetraethylammonium-OH, 10
EGTA, and 20 HEPES, pH 7.0. Unless noted otherwise, the stan-
dard pipette solution contained (mM): 20 
 
N
 
-methylglucamine
(NMG)
 
1
 
-Cl, 100 NMG–2-(
 
N
 
-morpholino)ethanesulfonic acid (MES),
2 magnesium sulfamate, 4 calcium sulfamate, 0.02 ouabain, and
20 HEPES, pH 7.0. Equimolar NMG was substituted for Na
 
1
 
, and
MES was substituted for Cl
 
2
 
.
 
results 
 
Basic Properties of GAT1-mediated Currents in Giant Oocyte 
Membrane Patches 
Experimental deﬁnition of GAT1 current.
 
Giant membrane
patches from control oocytes exhibited no GABA-activated
Figure  1. Perspectives on the
minimum reactions involved in
forward and reverse GAT1 trans-
port. (A) Forward (GABA uptake)
transport mode. Starting in the
upper left, one Na1 can be oc-
cluded from the extracellular side
in a slow reaction that is strongly
electrogenic (i.e., a large light-
ning bolt). Thereafter, Cl2,
GABA, and a second Na1 bind
and are translocated to the cyto-
plasmic side in a “fast” reaction
that is electroneutral. Finally,
transporter binding sites reorient
to the outside-open position when
no substrates are bound on the cy-
toplasmic side. This reaction is
fast and weakly voltage dependent
(i.e., small lightning bolt). (B) Re-
verse (GABA extrusion) trans-
port mode. Starting in the lower
left, Cl2 and Na1 can bind from
the cytoplasmic side. One Cl2 and one Na1 are occluded in a slow reaction with weak voltage dependence (i.e., small lightning bolt). Thereaf-
ter, one Na1 and one GABA bind and are translocated in a fast electroneutral reaction. When empty binding sites are open to the extracellular
side, one Na1 ion is still occluded in the transporter. This Na1 ion is released to the outside in a fast, strongly voltage-dependent reaction (i.e.,
large lightning bolt), and, in close association with this reaction, binding sites rearrange to the cytoplasmic side-open conﬁguration. 
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currents (data not shown). Fig. 2 A shows the typical
GABA-activated currents recorded in giant membrane
patches from oocytes expressing GAT1. Outward cur-
rent is activated when GABA (20 mM) is added to a cy-
toplasmic solution containing 120 mM NaCl, whereby
the extracellular (pipette) solution contains 20 mM Cl
 
2
 
and no GABA or Na
 
1
 
. Inward current is activated in the
absence of cytoplasmic GABA, Na
 
1
 
, and Cl
 
2
 
 when
GABA (0.2 mM) is added via pipette perfusion with a
pipette solution that contains 100 mM NaCl. Inward
currents at 0 mV were typically manyfold smaller than
outward currents at 0 mV. In stable patches, the GABA-
induced currents showed no change in magnitude for
over 30 min.
Fig. 2 B illustrates our standard protocol for studying
the voltage dependence of steady state transport cur-
rent. When the membrane current reached a new
steady value after solution changes, the voltage proto-
col described in Fig. 2 B (middle) was applied. This is
the cause of the current spikes a–d in Fig. 2 A. Typically,
we used cumulative membrane voltage steps of 30 mV
magnitude from 0 to –150 mV, up to 
 
1
 
90 mV, and back
to 0 mV. The step durations were just long enough
(17.5 ms in Fig. 2 B) so that pre–steady state transients
of the inward GAT1 current decayed for the most part
during each step. Fig. 2 B (top) shows the membrane
current response during (a) and after (b) the applica-
tion of cytoplasmic GABA, and the difference (a–b) is
shown below. The same procedure was used to obtain
membrane current responses before (c) and during
(d) extracellular GABA application by pipette perfu-
sion. The subtracted record (d–c) reveals pre–steady
state current transients that are faster at negative poten-
tials. To obtain the steady state current–voltage (I–V) re-
lation of the subtracted current, the median current
magnitude of the last 3 ms of each voltage step is plot-
ted against membrane voltage (Fig. 2 C). The I–V rela-
tions are monotonic. There is little or no hysteresis in
Figure 2. Deﬁnition of GAT1-mediated currents and I–V relations. (A) Chart record of membrane current at 0 mV: extracellular and cy-
toplasmic solutions were as indicated in millimolar. Outward GAT1 current was activated by applying 20 mM cytoplasmic GABA in the
presence of 120 mM cytoplasmic NaCl. After washing off all cytoplasmic substrates with 120 mM NMG-MES, extracellular solution was
changed to 120 mM NaCl via pipette perfusion. Inward GAT1 current was then turned on and off by adding and removing 0.2 mM GABAo
from the pipette solution. (B) I–V protocol and the corresponding membrane current responses at the time points indicated in A. (C) I–V re-
lations of GABA-deﬁned outward and inward GAT1 current. The median current amplitudes during the last 3 ms of each voltage step in B
are plotted against membrane potential. 
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the outward I–V relation, and the moderate hysteresis
present in the inward I–V relation is expected from the
slow time-dependent processes in the forward trans-
port cycle (Mager et al., 1993).
Fig. 3 shows that outward transport currents can be
deﬁned by two different means with very similar results.
The extracellular solution contains Na
 
1
 
 (120 mM) but
no GABA to test for GAT1-mediated inward current in
the absence of GABA. (Fig. 3, 
 
j
 
) Deﬁnition of trans-
port current by applying and removing 20 mM GABA
from the cytoplasmic side; (
 
h
 
) the deﬁnition by apply-
ing NO-711, a high-afﬁnity GABA uptake inhibitor,
from the cytoplasmic side in the presence of 20 mM cy-
toplasmic GABA. The results are ﬁtted by the Boltz-
mann equation, given in 
 
materials and methods
 
, and
the equivalent charge is 0.63. This slope is two-times
larger than in the absence of Na
 
1
 
o
 
. (Fig. 2 C) Pipette
perfusion experiments that deﬁne the effect of Na
 
1
 
o
 
 
 
in
I–V’s in a single experiment are described in Fig. 6 A of
a companion article (Hilgemann and Lu, 1999). If
GAT1 mediated an uncoupled Na
 
1
 
 current, these I–V
relations would cross the zero current line and display
an inward current component. That is not the case. As
shown further in Fig. 3 (
 
d
 
), the presence of NO-711
(0.13 mM)
 
 
 
on the cytoplasmic side completely blocks
GABA-activated current.
 
Failure to detect GABA-independent GAT1 currents. 
 
In re-
lated experiments, we used NO-711 to further test
whether GAT1 mediates ionic currents in the absence of
GABA. In patches expressing GAT1, current responses
to membrane voltage changes before and after applying
NO-711 were compared, and no NO-711–inhibited cur-
rent was clearly detected. Protocols used to deﬁne
GAT1 charge movements (Lu and Hilgemann, 1999)
provide one example. We point out that our ability to
resolve small Na
 
1
 
 currents is limited by the 
 
Xenopus oo-
cyte Na1 conductance. This conductance is slowly acti-
vated by depolarization beyond 220 mV in patches (He
et al., 1998). It is large in many oocyte batches. Al-
though it decreases continuously over 10–20 min after
patch excision, a residual conductance is persistent.
Outward I–V relations were also deﬁned by addition
and removal of cytoplasmic Cl2 or Na1, leaving the
other substrate concentrations constant (not shown).
Results for Cl2, using MES as the Cl2 substitute, were
virtually identical to those with GABA subtraction. This
indicates that, in the absence of cytoplasmic Ca21, the
Cl2 conductance of the oocyte membrane patches is
very small. Results for Na1, using NMG as the Na1 sub-
stitute, were also very similar to those with GABA sub-
traction, provided that GAT1 expression was high and
the endogenous Na1 conductance of the oocyte patch
had run down. In general, however, the Na1 conduc-
tance of the oocyte membrane complicates results ob-
tained with Na1 subtraction.
Strict cosubstrate requirements of outward GAT1 current.
In our experience, activation of outward GAT1 trans-
port current in oocyte patches requires the simulta-
neous presence of GABA, Na1, and Cl2 on the cytoplas-
mic side. Activation by each substrate in the presence
of cosubstrates is demonstrated in Fig. 4. The results
were obtained using a fast solution switch device
whereby the pipette tip is moved in ,3 ms through the
interface between two solution streams by a computer-
controlled manipulator (Hilgemann and Lu, 1998). We
present results from a patch with relatively low GAT1
expression since these results illustrate our reasons for
deﬁning GAT1 current with GABA application and re-
moval in subsequent experiments. Dotted lines in Fig. 4
indicate the zero current level. Fig. 4 A shows the cur-
rent record for applying and removing 20 mM cytoplas-
mic GABA in the presence of 120 mM NaCl. The out-
ward current activates to a plateau in z30 ms on apply-
ing GABAi, and the current returns to baseline with an
S-shaped time course over z200 ms. The patch has a
small “leak current” (,1 pA) in the presence of 120
mM NaCli. Due to the rise of the membrane into the pi-
pette tip (z50-mm diameter), the time courses of cur-
rent activation and deactivation are, with good certainty,
determined by the diffusion of GABA up to and away
from the membrane, respectively. The rate of activation
is relatively fast because the transporter binding sites
become saturated with GABAi before diffusion equilib-
rium is reached. The time course of deactivation is slow
because the concentration of GABAi at the membrane
Figure 3. Outward GAT1 transport current deﬁned by cytoplas-
mic GABA and NO-711. Outward GAT1 transport current acti-
vated by 20 mM cytoplasmic GABA (120 mM NaCl on both mem-
brane sides) was deﬁned by removing GABA with substitution by
aspartate (j) and by applying 0.13 mM NO-711 in the continued
presence of GABA (h) on the cytoplasmic side. Note that the two
subtraction protocols give very similar results. The results were
therefore pooled and ﬁtted by the Boltzmann equation described
in materials and methods (solid line; equivalent charge, 0.63).
(d) Subtraction of an I–V relation with GABA from one without
GABAi in the presence of 0.13 mM cytoplasmic NO-711.434 Steady State Studies of GAT1
must decrease substantially before binding sites are
freed of GABAi.
Fig. 4 B shows the record obtained on applying 120
mM Cl2
i, instead of 120 mM MES2
i, in the presence of
20 mM GABAi and 120 mM Na1
i. Current activation is
just as fast as with GABAi because the half-maximal Cl2
i
concentration is only z10 mM at 0 mV (see Fig. 8 F).
The current relaxation on removal of Cl2
i is, however,
biphasic. The fast phase of relaxation is probably an ar-
tifact caused by the liquid junction potential of these
two solutions (z8 mV), and this will affect the driving
force for both leak current and transport current.
Thus, Cl2
i deﬁnition of GAT1 current will have signiﬁ-
cant artifactual components, particularly with low trans-
port activities, high Cl2
i concentrations, and at extreme
potentials.
Fig. 4 C shows the typical result obtained for applica-
tion of 120 mM Na1
i in the presence of 20 mM GABAi
and 120 mM Cl2
i, using NMG1 as the Na1 substitute. In
this case, removal of Na1
i causes a small inward back-
ground Na1 current (,5 pA at 0 mV), which probably
reﬂects Na1-mediated leak current through the patch
seal. The activation of GAT1 transport current by Na1
i
application is somewhat slower than by GABAi and Cl2
i.
This is because 120 mM Na1
i does not “super-saturate”
binding sites. The current deactivates faster than with
the other substrates because the Na1
i dependence of
the current is sigmoidal (see Fig. 8 B and 9 C). From
these results, we conclude that GAT1 transport current
is best deﬁned with GABA application and removal,
and GABA deﬁnition is used in subsequent results.
Failure to detect secondary “gating” or “trans-activation”
mechanisms for GAT1. In experiments similar to those
just described, we tested extensively whether the GAT1
transporter undergoes substrate- and time-dependent
activity changes via “secondary modulation” or “inacti-
vation” reactions, analogous to reactions identiﬁed for
cardiac Na1–Ca21 exchange (Hilgemann, 1990; Mat-
suoka and Hilgemann, 1994). In short, we have found
no evidence for such behaviors, on either long or short
time scales, down to the time scale of the slow extracel-
lular Na1-dependent GAT1 charge movements (z20
ms) described in the next article (Lu and Hilgemann,
1999). Using pipette perfusion, we also tested whether
inward or outward GAT1 currents could be enhanced
by the presence of substrates or monovalent ions on
the opposite membrane side, as reported for GAT1 cur-
rents recorded in stably transfected HEK293 cells
(Cammack and Schwartz, 1994). We did not observe
any trans-activation effect.
Possible existence of Cl2
o -independent inward GAT1 cur-
rent component. In contrast to the evident tight sub-
strate-current coupling in the activation of reverse (out-
ward) transport current in oocyte patches, forward
transport current can be partially activated by extracel-
lular GABA in the nominal absence of extracellular
Cl2. Fig. 5 shows records from a single patch: (a) the
outward current activated by 20 mM GABAi with 120
mM NaCl on both membrane sides. (b) The NO-711i-
sensitive inward current with 0.4 mM GABAo, 120 mM
Na1
o, no Cl2
o, and no cytoplasmic substrates. (c) The
NO-711i-sensitive inward current with 0.4 mM GABAo,
120 mM NaClo, and no cytoplasmic substrates. The
Cl2
o-independent inward current (Fig. 5, b) is more
signiﬁcant at negative membrane potentials (at –120
mV,  z40% of that with 120 mM Cl2
o). These results are
comparable with results in intact oocytes (Mager et al.,
1993; D.D.F. Loo, S. Eskandari, and E.M. Wright, per-
sonal communication).
GAT1 reversal potentials.  To further probe substrate
coupling by the GAT1 transporter, we measured reversal
potentials with various extracellular-to-cytoplasmic sub-
strate ratios and compared them with the expected rever-
sal potentials, Vrev, for 1GABA:2Na1:1Cl2 stoichiometry:
Figure 4. Activation and deactivation of reverse GAT1 current
by rapid solution changes. (A) Application and removal of 20 mM
cytoplasmic GABA. (B) Application and removal of 120 mM cyto-
plasmic Cl2. (C) Application and removal of 120 mM cytoplasmic
Na1. Fast changes of cytoplasmic solutions were achieved by mov-
ing the recording pipette, which was attached to a computer-con-
trolled piezoelectric device, between two steady streams of differ-
ent cytoplasmic solutions. The extracellular solution contained 20
mM Cl2 and no Na1. See text for further explanations.435 Lu and Hilgemann
where R, T, and F have their usual meanings. For these
measurements, I–V relations were determined with all
substrates on both membrane sides, before and after
extracellular application of the high-afﬁnity organic
GAT1 inhibitor NO-711 via pipette perfusion. We note
that cytoplasmic NO-711 did not block effectively the
GAT1-mediated currents under these conditions, pre-
sumably because GABA binding sites are occupied on
both membrane sides. Fig. 6 A shows a typical GAT1
I–V relation with a measured Vrev of 45 mV. With the
substrate concentrations employed (see Fig. 6, legend),
the predicted value is 97 mV.
Fig. 6 B shows results obtained with a variety of sub-
strate concentrations. The scatter of experimental re-
sults is rather large in the repeated measurements, and
this reﬂects the fact that GAT1 current amplitudes in
these conditions are rather small. With 120 mM NaCl
and 2 mM GABA on both sides, for example, we could
not deﬁne any GAT1 current. Nevertheless, all of the
measured Vrev’s, summarized in Fig. 6 B, scatter along
the theoretical line without systematic deviation. Thus,
within our experimental limitations, we ﬁnd no contra-
diction to the idea that GAT1 transport is a well-cou-
pled process.
No effect of osmotic gradients on outward GAT1 current.
Since activation of outward GAT1 current with GABA
involves changing solution osmolarity by up to 20 mos-
mol/liter, we tested whether osmotic strength and/or
transmembrane osmotic gradients result in any alter-
ation of GAT1 current. We observed no effects of osmo-
larity changes using dextrose, aspartate, glutamate, or
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polyethylene glycol (not shown). In a related issue, Loo
et al. (1996) have reported that GAT1 transports water
in a manner similar to the brush border Na1/glucose
cotransporter, where .200 water molecules appear to
be directly coupled to the transport of each sugar mole-
cule. We therefore tested the effect of changing water
concentration on GAT1 transport. There was no clear
effect on the outward GAT1 transport current when
30% of water molecules were replaced by low molecu-
lar weight polyethylene glycol.
Alternating Access Versus Single-ﬁle Channel Models
of Cotransport
For some ion channels, it is established that ions per-
meate in a single-ﬁle fashion along multiple binding
sites (Hille, 1992). When two ion species can permeate
a channel, permeation of one ion species can sweep the
other ion species through the channel against its elec-
trochemical gradient. This mechanism allows a cotrans-
port function to be established in an ion/substrate
“hopping” model when it is assumed that a substrate
such as GABA can permeate through a Na1-selective
channel (Su et al., 1996). Speciﬁcally, the “multisub-
strate single-ﬁle” model assumes that Na1 and a sub-
strate “hop” through a pore with three sites that can
bind either the substrate or Na1. The model permits
ﬂux-coupling without generating large Na1 leak cur-
rents in the absence of substrate, and it can recreate a
number of results on GAT1 function. We now compare
its function with an “alternating access” model that
“simultaneously transports two substrates (Jauch and
Läuger, 1986).
Fig. 7 illustrates predictions for trans- and cis-substrate
interactions in the two models (A and D) that we con-
Figure  5. I–V relations of
GABA-activated currents in the
presence and nominal absence
of extracellular Cl2. The patch
was obtained using a pipette so-
lution with 120 mM extracellular
Na-MES and 0 Cl2
o, whereby a
300-mM KCl “agar bridge” was
used in the pipette. Outward
transport current was deﬁned by
substituting 20 mM GABA for 20
mM aspartate in the presence of
120 mM NaCl on the cytoplasmic
side. After replacing the cytoplas-
mic solution with 120 mM NMG-
MES, inward current was acti-
vated with extracellular GABA in
the presence of Na1
o. Both were
deﬁned with a 0.4 mM GABAo
subtraction. The extracellular so-
lution in b contained 120 mM Na-MES and was Cl2 free; in c the extracellular solution contained 120 mM NaCl, which was applied by pi-
pette perfusion. The voltage steps were 35 ms in duration. Data points represent the average of current magnitudes at the speciﬁed mem-
brane potential during the cumulative voltage protocol.436 Steady State Studies of GAT1
sider fundamental. Predictions for the channel-like
model are shown in Fig. 7, B and C; those for the alter-
nating access model are shown in E and F. We simu-
lated the channel model with our own software using
the published parameter values (Su et al., 1996), and
we checked that our implementation accurately recre-
ated all published steady state simulations. Also, we
checked that the model did not contradict thermo-
dynamic constraints under a wide range of conditions.
An inherent feature of the channel-like model is that
binding of a substrate on one side of the membrane
tends to be prevented by substrate ﬂux from the oppo-
site side. Thus, addition of Na1 to the trans side de-
creases the apparent afﬁnity for GABAi to activate
transport from the cis side (Fig. 7 B). On the other
hand, substrates on the same (cis) membrane side com-
pete for entrance into the pore. Thus, reduction of
[Na1]i results in an increase in the apparent afﬁnity for
GABAi (Fig. 7 C).
We use the simple cotransport model in Fig. 7 D to il-
lustrate the equivalent predictions for an alternating
access scheme. In this simulation, the cotransporter
binds its substrates X and Y instantaneously and inde-
pendently. The presence of a trans substrate (e.g., Xo)
reduces the rate of the “empty carrier translocation” or
“return” step (1) in the transport cycle, thereby limit-
ing the rate of transport from the cis side. When the re-
turn step is slow, the apparent afﬁnity for cis substrates
(e.g., Yi) is higher. The fractional increase of afﬁnity for
cis substrates should be proportional to the fractional
decrease of maximal transport induced by addition of
the trans substrate.
The predictions for X 5 Na1 and Y 5 GABA are
shown in Fig. 7 E, together with the corresponding data
from a pipette perfusion experiment. The simulated
GABAi dependencies (solid lines) are scaled to the
measured magnitudes of outward GAT1 currents with
(s) or without (d) 100 mM extracellular Na1 at 0 mV.
In the presence of high [Na1]o, the maximal GABAi-
induced current is decreased, and the apparent afﬁnity
of GAT1 for GABAi is increased. The half-maximum
GABAi concentrations are 0.90 and 0.52 mM, respec-
tively, in the absence and presence of 100 mM Na1
o.
Clearly, the data agrees well with the simple alternating
access transport model, but not the “channel model”
(Fig. 7 B).
Fig. 7 F shows predictions for cis-substrate interac-
tions by the same alternating access model (Fig. 7 D;
X 5 Cl2 and Y 5 GABA), together with the corres-
ponding experimental data. With a rate-limiting empty
carrier translocation step in the reverse transport cycle,
outward transport current activated by one substrate
(e.g., Yi or GABAi) becomes smaller if the concentra-
tion of its cis cosubstrate (e.g., Xi or Cl2
i) is lowered.
This reduction in current amplitude is “overcome” by a
sufﬁciently high concentration of Yi, and a reduction of
the cis-cosubstrate concentration results in a decreased
apparent afﬁnity for the substrate. This is the case here
because the maximal transport rate is determined by
the rate of the return step (Fig. 7 D, 1), rather than the
translocation steps (2) from the cis side. From other
Figure 6. Reversal potential measurements of GAT1 current. (A)
GAT1 transport current with all three substrates on both mem-
brane sides was deﬁned by pipette perfusion of NO-711 (13 mM) to
the extracellular side. The pipette (extracellular) solution con-
tained 0.4 mM GABA and 120 mM NaCl; the bath (cytoplasmic) so-
lution contained 2 mM GABA, 60 mM Na1, and 6 mM Cl2. (B)
NO-711o–deﬁned reversal potentials are plotted against the theo-
retical values for various conditions listed below the graph. All re-
versal potentials were measured at 358C. The dotted line represents
the values predicted for perfect 2Na1:1Cl2:1GABA stoichiometry.437 Lu and Hilgemann
observations, we expect that the empty carrier translo-
cation step in GAT1 becomes rate limiting during re-
verse transport only in the presence of high extracellu-
lar Na1. As shown by the data in Fig. 7 F with 120 mM
extracellular NaCl, reduction of [Cl2]i from 120 to 30
mM shifts the half-maximal concentration for GABAi
from 0.3 to 2.7 mM, while the maximal transport cur-
rent is decreased by only 25%. This pattern is well simu-
lated by the model in Fig. 7 D (Fig. 7 F, solid lines). In
contrast, the channel model predicts that reduction of
a cis cosubstrate (i.e., Na1
i) increases the apparent af-
ﬁnity for GABAi (Fig. 7 C) since GABAi competes with
Na1
i for entrance to the pore. Thus, both cis–trans and
trans–trans substrate interactions of GAT1 are pre-
dicted by alternating access models of cotransport, and
they contradict the channel-like model of cotransport.
Up to now, we could not envision any modiﬁcations of
the channel model that would predict the substrate de-
Figure 7. Comparison of predictions from a “multi-substrate single-ﬁle model” and a two-state alternating access model. (A) Multi-sub-
strate single-ﬁle transport model for GAT1 (Su et al., 1996). The channel contains three single-ﬁle binding sites that can accommodate ei-
ther GABA or Na1, and the substrates “hop” between them. (B) Simulation of the “trans-effect” of Na1
o on the GABAi dependence of out-
ward GAT1 transport current. (C) Simulation of the “cis-effect” of Na1
i on the GABAi dependence of outward GAT1 transport current in
the presence of Na1
o. In both cases, [Na1]i is not limiting and [GABA]o is zero. (D) A two-state alternating-access model for a simulated
“XY-cotransporter,” where efﬂux of X and Y generates outward transport current. The two time-dependent steps (arrow pairs) of the trans-
port cycle are the rearrangement of binding sites in the empty (1) and fully loaded (2) transporters. The equations employed were equiv-
alent to those used for more extensive simulations (Hilgemann and Lu, 1999). The intrinsic transition rates for fully loaded and empty
binding sites were equal. Double-headed arrows indicate “instantaneous” association/dissociation of the substrates. (E) Comparison of the
measured effect of extracellular Na1 on outward GAT1 current with the simulated trans-effect of Xo. Cytoplasmic GABA concentration de-
pendence of the outward GAT1 current with 120 mM cytoplasmic NaCl at 0 mV was measured in the absence (d) or presence (s) of 100
mM Na1
o. Solid lines represent simulated Yi dependence of outward transport current when [X]i is not limiting and [Y]o is zero, where the
fraction of transporters with Xo bound (fxo) is 0.6 (upper curve) or 1 (lower curve). (F) Comparison of the measured effect of lowering cy-
toplasmic Cl2 on outward GAT1 current with the simulated cis-effect of Xi. Cytoplasmic GABA dependence of the outward GAT1 current
with 120 mM extracellular NaCl at 0 mV was measured with 120 mM (d) or 30 mM (s) cytoplasmic Cl2. Solid lines represent the simu-
lated Yi dependence of outward transport current in the presence of Xo (fxo 5 0.8) and non-limiting Xi, where the fraction of transporters
with Xi bound (fxi) is 1 (upper curve) or 0.4 (lower curve).438 Steady State Studies of GAT1
pendencies of the alternating-access model. Also, we
point out that our results are consistent with substrates
being transported simultaneously, rather than sequen-
tially, as concluded previously by Jauch and Läuger
(1986) for a Na1–alanine cotransporter.
Effects of Other Extracellular Substrates on Outward
GAT1 Current
We have tested whether extracellular GABA at concen-
trations up to 1 mM affects the outward current in the
absence of extracellular Na1, and no clear effect was
observed. For extracellular Cl2, we have detected only
a small inhibition of outward current (z20%) with 120
mM versus nominally Cl2 free extracellular solution in
the absence of extracellular Na1.
Outward GAT1 Transport Current: Voltage and 
Substrate Dependencies
To gain insight into how substrate interactions with
GAT1 are affected by membrane potential, we ﬁrst
measured the I–V relations of outward GAT1 current
over a wide concentration range for one substrate,
while leaving the other substrates at ﬁxed high (“satu-
rating”) concentrations. A data set for each GAT1 sub-
strate could then be replotted as a series of concentra-
tion–current relations at different membrane poten-
tials, and the maximal current amplitude (Imax) and
half-maximum concentration (K1/2) for that substrate
could be obtained by ﬁtting the concentration–current
relations by a Hill equation:
where I is the outward transport current magnitude,
[S] is the substrate concentration, and nH is the Hill co-
efﬁcient.
The corresponding substrate dependencies are
shown in Fig. 8, whereby the GABAi, Na1
i, and Cl2
i de-
pendencies of GAT1 outward current at 0 mV are given
in A–C, respectively. The corresponding voltage depen-
dencies of Imax, K1/2, and nH, are shown in Fig. 8, D–F,
respectively. The Imax–V relations are ﬁt by the Boltz-
mann equation given in materials and methods (Fig.
8, D–F, top, solid lines). In each case, the equivalent
charge is close to 0.3. Only small changes of I–V shapes
were detected with changes of substrate concentrations:
I–V’s become slightly less steep with low GABA concen-
trations and slightly steeper at very low [Na1]i.
The ﬁtted nH and K1/2 are both relatively voltage inde-
pendent (Fig. 8, D–F). At membrane potentials be-
tween  230 and 190 mV, where measurements are most
reliable, nHs are 1.2–1.4 for Na1
i and 0.9–1.1 for Cl2
i. nH
for the GABA dependencies was always close to 1, and it
was therefore ﬁxed at 1 for this presentation. Over the
II max
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same range of 230 to 190 mV, the K1/2s are 2.2–2.8
mM for GABAi, 53–83 mM for Na1
i, and12.1–13.6 mM
for Cl2
i. In the more negative potential range there is a
trend for the K1/2’s for Na1
i and Cl2
i to increase.
Outward GAT1 Transport Current: Cytoplasmic
Substrate Interactions
Fig. 9 describes how GAT1 substrates interact from the
cytoplasmic side in the activation of outward transport
current. Since the effects of voltage were minor in
these interactions, we present only the data at 0 mV.
Our protocol was to maintain a high concentration of
one of the three substrates, and then systematically ex-
amine the effects of lowering one of the other two sub-
strates on the concentration dependence of the third
substrate. The transport current in all cases is deﬁned
by application and removal of cytoplasmic GABA with
otherwise ﬁxed substrate concentrations. In all results,
the pipette solution contains 20 mM Cl2, no Na1, and
no GABA. The solid lines presented with the data
points in Fig. 9 represent ﬁts by the functional model
we developed for GAT1, which is detailed in another
article (Hilgemann and Lu, 1999).
Fig. 9 A shows the cytoplasmic GABA dependencies
of transport current. The data points were ﬁt by the
Hill equation with nH 5 1 to obtain the corresponding
Imax’s and K1/2’s (not shown). When [Na1]i was lowered
from 120 to 30 mM with 120 mM cytoplasmic Cl2, the
Imax decreased from 155.3 to 30.7 pA, while the K1/2 re-
mained unchanged (2.2 and 2.1 mM, respectively, Fig.
9 A, top graph). Similar effects were obtained when re-
ducing cytoplasmic Cl2 with 120 mM cytoplasmic Na1
(bottom graph). The Imax is 98.4 pA and the K1/2 is 2.0
mM at 60 mM Cl2
i; at 3 mM Cl2
i the Imax and K1/2 val-
ues are 69.4 pA and 2.9 mM, respectively.
Fig. 9 B shows the cytoplasmic Na1 dependencies of
the transport current. The top graph shows the effect
of changing cytoplasmic GABA from 20 to 2 mM with
120 mM cytoplasmic Cl2: the nH obtained from ﬁt by
the Hill equation (not shown) increased from 1.2 to
2.1, the K1/2 for Na1
i changed only slightly, and the Imax
decreased by 40%. The bottom graph shows the effect
of reducing Cl2
i from 50 to 5 mM with 12 mM GABA:
the K1/2 for Na1
i increased by twofold (123 vs. 58 mM),
while the nH and the Imax changed only slightly (80 vs.
73 pA).
Fig. 9 C shows the cytoplasmic Cl2 dependencies of
the transport current. These results were ﬁt by the Hill
equation with nH 5 1 (not shown). The Imax is reduced
from 59 pA at 100 mM Na1
i to 9.8 pA at 20 mM Na1
i,
while the K1/2 is increased from 4 to 12 mM. Reduction
of [GABA]i also decreases the Imax for Cl2 (239 pA at 20
mM GABAi vs. 155 pA at 2 mM GABAi), but the K1/2 in-
creases by only 25% at low [Na1]i (12 mM at 20 mM
GABAi vs. 15 mM at 2 mM GABAi).439 Lu and Hilgemann
Only Cl2 Can Interact with the Empty GAT1 Transporter 
from the Cytoplasmic Side
The substrate concentration dependencies presented
in the previous section are predicted precisely by a bind-
ing scheme for GAT1 cytoplasmic substrates (Scheme I),
where two Na1
i and one Cl2
i bind sequentially (Cl2
i–
Na1
i–Na1
i) and GABAi binding is independent of Cl2
i
and Na1
i. In this binding scheme, reduction of [Cl2]i
will be overcome by high [Na1]i, and GABAi will not af-
fect the apparent afﬁnities of the other cosubstrate.
Also, this binding order is mostly consistent with our ca-
pacitance data, which indicate that Cl2
i interacts with
the empty transport in the absence of other cosub-
strates (Lu et al., 1995). However, there are three fur-
ther predictions: (a) cytoplasmic GABA should inhibit
the inward GAT1 current because it can bind from the
cytoplasmic side in the absence of cosubstrates; (b) the
apparent afﬁnity for Cl2
i binding, when measured as a
capacitance change, should increase in the presence of
high [Na1]i; and (c) inhibition of inward current by
Cl2
i should be enhanced by Na1
i, just as lowering
[Na1]i decreases the maximal outward current acti-
vated by Cl2
i (Fig. 9 C). These predictions were tested
in the following experiments.
As described previously, inward transport current can
be repeatedly activated in the patch using the pipette
perfusion technique (Fig. 1). Fig. 10, A and B, present
I–V relations of the inward transport current deﬁned
by 0.2 mM extracellular GABA in the presence of 120
mM extracellular NaCl. The activation of inward trans-
port current does not require any cytoplasmic ions, nor
(SCHEME I)
Figure 8. Cytoplasmic substrate dependencies of outward GAT1 transport current. (A–C) Cytoplasmic GABA (A), cytoplasmic Na1 (B),
and cytoplasmic Cl2 (C) dependencies of GAT1 outward transport current at 0 mV. Half-maximal substrate concentrations (K1/2s) were
obtained from ﬁts by the Hill equation (solid lines). (D–E) Voltage dependencies of Imaxs, K1/2s, and nHs from the Hill ﬁts for cytoplasmic
GABA, Na1, and Cl2. The Imax–V relations were ﬁt by the Boltzmann equation given in materials and methods. The slope coefﬁcients
are 0.3, 0.36, and 0.29 in D–F, respectively. The ﬁts of GABAi dependencies (D) assumed a Hill coefﬁcient of 1. Results in A and D are from
one patch, and results in B, C, E, and F are from another patch.440 Steady State Studies of GAT1
is inward current enhanced by cytoplasmic ions. As
shown in Fig. 10 A, the presence of high cytoplasmic
Na1 alone (120 mM) has a weak inhibitory effect, and
GABA alone (20 mM) has almost no effect. A 25–50%
inhibition of the inward current is achieved with the
combined application of Na1
i and GABAi. In contrast,
cytoplasmic Cl2 strongly inhibits the inward transport
current. The inhibition by Cl2 is monotonic, and its
concentration dependence at 0 mV is shown in Fig. 10
C. These data points are from additional measure-
ments in the same patch, and the solid line represents a
ﬁt by the equation
where Imax is the current magnitude without Cl2
i, and
K1/2 is the [Cl2]i at which inward current is reduced by
50%. Inward currents were deﬁned by subtraction of
records with and without extracellular GABA. In the
presence of 120 mM cytoplasmic Cl2, .90% of the in-
ward current is inhibited. The K1/2 from the ﬁt is 12.4
mM. We also examined the kinetics of inhibition by
performing automated concentration jumps, and we
resolved no slow components of inhibition that would
not be explained by diffusion of Cl2
i to and away from
the patch (not shown).
In Fig. 11, we have used the capacitance method to
further analyze the interactions between GAT1 and its
substrates. These results were obtained using 10 kHz/1
mV sinusoidal voltage perturbations. Fig. 11 A illus-
trates the membrane capacitance responses obtained
I
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when a patch is rapidly switched from high to 0 Cl2
cytoplasmic solution. The magnitude of capacitance in-
crease is larger when the cytoplasmic solution also con-
tains GABA and Na1. Fig. 11 B shows the cytoplasmic
Cl2 dependence of the capacitance change under four
conditions: with high GABAi and high Na1
i, with high
GABAi only, with high Na1
i only, and with no GABAi or
Na1
i. GABA and Na1 alone do not alter much the Cl2
i-
induced capacitance change. However, the simulta-
neous presence of cytoplasmic Na1 and GABA results
in two changes in the capacitance signal. First, the Cl2
i-
induced capacitance change is larger at all concentra-
tions. Second, there is a fourfold decrease of the half-
maximal Cl2
i concentration.
Together, the results described in Figs. 10 and 11
present deﬁnitive contradictions to the simple binding
scheme for GAT1 cytoplasmic substrates discussed
above. First, GABAi alone cannot inhibit the inward
current (Fig. 10 A) or affect a change of capacitance
(Fig. 11 B) in the absence of the other substrates. Sec-
ond, Na1
i does not strongly increase the apparent afﬁn-
ity for Cl2
i (Fig. 11 B, j vs. h). An adequate account of
this data therefore requires a systematic simulation ef-
fort to model GAT1 function, and this is presented in
an accompanying article (Hilgemann and Lu, 1999).
discussion
GAT1 Function Can Be Simple
This study has demonstrated that GAT1-mediated
transport currents behave largely as expected for a sim-
ple alternating-access cotransporter in the steady state.
Figure 9. Cytoplasmic sub-
strate dependencies of outward
GAT1 transport current at 0 mV.
(A) Cytoplasmic GABA depen-
dence with 120 and 30 mM cyto-
plasmic Na1 (upper graph) and
with 60 and 3 mM cytoplasmic
Cl2 (lower graph). (B) Cytoplas-
mic Na1 dependence with 20 and
2 mM cytoplasmic GABA (upper
graph) and with 50 and 5 mM cy-
toplasmic Cl2 (lower graph). (C)
Cytoplasmic Cl2 dependence with
100 and 20 cytoplasmic Na1 (up-
per graph) and with 20 and 2
mM cytoplasmic GABA (lower
graph). Solid lines are predicted
results from ﬁtting an entire data
base on GAT1 function by an al-
ternating access model (Hilge-
mann and Lu, 1999).441 Lu and Hilgemann
The Hill slopes of the substrate concentration depen-
dencies and the measured reversal potentials are all
consistent with the usual postulated stoichiometry of
1GABA:2Na1:1Cl2 for GAT1. Admittedly, the reversal
potential measurements show considerable scatter.
However, the reverse GAT1 current absolutely requires
the presence of GABA and both co-ions. Neither the re-
verse nor the forward current requires the presence of
any trans ions, nor have we observed any trans-stimula-
tion effects of substrates. Our conclusion, that GAT1
can function as a simple transporter with ﬁxed stoichi-
ometry, is similar to that of Jauch et al. (1986) for a
Na1–alanine cotransporter that could be studied in
pancreatic acinar cells with pipette perfusion.
Our results are strikingly different from those of
Cammack et al. (1994), who employed whole-cell volt-
age clamp to study GAT1 transiently expressed in
HEK293 cells. In their study, “ex-gated” (i.e., GABAo
dependent) and “in-gated” (GABAi dependent) cur-
rents were differentiated; both required the presence
of monovalent cations and/or anions on the trans-
membrane side. In addition, the authors reported that
GAT1 has modes of action that contradict the expecta-
tions for a tightly coupled “conventional transporter:”
“leak” currents were observed in the absence of GABA,
suggesting that real ion channels are formed by a small
fraction of the expressed GAT1 transporters (Cam-
Figure 10. Effects of cytoplasmic substrates on I–V relations of
the inward GAT1 current. Inward GAT1 current is deﬁned as the
current activated by 0.2 mM extracellular GABA via pipette perfu-
sion. (A) I–V relations of the inward GAT1 current in the absence
of cytoplasmic substrates (h), in the presence of 20 mM cytoplas-
mic GABA alone (j), in the presence of 120 mM cytoplasmic Na1
alone (m), and in the presence of 20 mM cytoplasmic GABA and
120 mM cytoplasmic Na1 (n). (B) Effect of cytoplasmic Cl2 on the
I–V relation of the inward GAT1 current. (C) Inhibition of the in-
ward GAT1 current by cytoplasmic Cl2 at 0 mV. Half-inhibition oc-
curs at 12.4 mM. See text for further details. The voltage protocol
used in A and B was identical to that in Fig. 2. Data points repre-
sent the average of current magnitudes at the speciﬁed membrane
potential during the cumulative voltage protocol.
Figure 11. GAT1 capacitance changes in response to rapid
changes of the cytoplasmic Cl2 concentration. (A) Membrane ca-
pacitance changes in response to removing cytoplasmic Cl2 were
measured in the absence (left) or presence (right) of both cyto-
plasmic GABA (20 mM) and cytoplasmic Na1 (120 mM). The Cl2
i
concentration is changed rapidly by an automated solution
switcher. (C) Cytoplasmic Cl2 concentration dependence of the
membrane capacitance change. Solid lines represent ﬁts by the
Hill equation with a ﬁxed slope factor (nH) of 1.442 Steady State Studies of GAT1
mack and Schwartz, 1996). These differences to our re-
sults might be due to different GAT1 functions in dif-
ferent expression systems (Xenopus versus mammalian).
Although our experience is limited, we have observed
evidence for such expression system-dependent differ-
ences: in excised giant patches from HEK293 cells,
transiently expressing GAT1, we found that the I–V of
reverse GAT1 current was nearly voltage independent
(data not presented).
Relations to Previous Oocyte Studies
Two-electrode voltage clamp studies with Xenopus oocytes
have previously provided much mechanistic insight
into the forward transport mode, which mediates
GABA uptake (Mager et al., 1993, 1996), and our stud-
ies now provide complementary data on the trans-
porter’s reverse mode. We can therefore outline several
clear differences between the two modes of operation.
(a) Although in the forward transport cycle Na1 seems
to bind to the empty transporter before Cl2 and GABA
at the extracellular side, in the reverse cycle the interac-
tion of Cl2
i with the transporter appears to be the ﬁrst
step. This is supported by the fact that only Cl2
i was
able to decrease capacitance of the empty carrier in a
concentration-dependent manner (Lu et al., 1995) and
that only Cl2
i strongly inhibits the forward transport
current (Fig. 11). (b) In the forward cycle, the rate-lim-
iting step at 0 mV is a strongly voltage-dependent reac-
tion; a voltage-independent step becomes rate limiting
at large negative potentials. In contrast, the rate-limiting
step of the reverse cycle is weakly voltage dependent,
and it remains rate limiting under virtually all condi-
tions; this explains the relative lack of shape changes of
I–V relations. (c) The transporter has extremely asym-
metrical afﬁnities for extracellular and cytoplasmic
GABA. The apparent afﬁnity for extracellular GABA is
more than two orders of magnitude higher than that
for cytoplasmic GABA. The concentrations of GABAo
that half-maximally activate inward GAT1 current
range from z6 mM at 220 mV to z20 mM at 2140 mV
when extracellular Na1 and Cl2 are not limiting
(Mager et al., 1993). Under comparable conditions, K1/2s
for cytoplasmic GABA are in the millimolar range (Fig.
8 D). (d) The apparent afﬁnities for extracellular
GABA and Na1 depend on membrane voltage, being
higher at more negative potentials. In contrast, the ap-
parent afﬁnities for cytoplasmic GABA, Na1, and Cl2
do not vary much with membrane potential (Fig. 8, D–F),
which is expected if the reverse cycle is always rate lim-
ited by a weakly voltage-dependent step.
Alternating Access versus Channel-like Models of 
GAT1 Function
The idea that cotransporters might operate in a chan-
nel-like fashion, without conformational changes, pre-
supposes that a pore structure could allow hydrophilic
molecules as large as GABA to bind speciﬁcally and per-
meate, while disallowing a nonspeciﬁc permeation of
ions. We know of no clear evidence that this is physically
possible, and we have presented two types of results for
GAT1 that contradict the channel model (Fig. 7). First,
addition of extracellular Na1 increases the apparent af-
ﬁnity for cytoplasmic GABA in parallel with a reduction
of the maximum reverse GAT1 current. Second, reduc-
tion of cytoplasmic Cl2 decreases the apparent afﬁnity
for GABAi in the presence of extracellular Na1, but not
in its absence. In addition, the Cl2
i-activated GAT1 ca-
pacitance changes become larger and saturate at lower
Cl2
i concentrations in the presence of both cosub-
strates (Fig. 11). This indicates that the binding of all
three substrates enables further transporter reactions,
presumably conformational changes. A ﬁnal well-known
property of alternating access models is that the pres-
ence of a substrate on one membrane side can stimu-
late transport of that substrate from the opposite side.
This “self-exchange” of substrates is not predicted by
the channel model, but it has been well documented
for the GABA transporter (Kanner et al. 1983).
Complex Cytoplasmic Substrate Interactions
The interactions of cytoplasmic substrates in the activa-
tion of the reverse current are not straightforward. As
noted above, it is evident that Cl2
i can bind in the ab-
sence of the other substrates. Furthermore, reduction
of Cl2
i shifts the Na1
i dependence of current to some-
what higher Na1
i concentrations, as expected if Na1
i
binds after Cl2
i. However, reduction of [Cl2
i] does not
shift the dependence of current on GABA, indicating
that GABAi probably binds independently from Cl2
i. It
is then perplexing that GABAi cannot inhibit the in-
ward current. Furthermore, Na1
i–GABAi interactions
are also suggestive of independent binding sites; maxi-
mal currents are decreased when either cosubstrate
concentration is reduced. That these complexities can
be accounted for in the context of a simple transport
model (Hilgemann and Lu, 1999) was highlighted in
this article by including simulations of our tentative
GAT1 model with the experimental data (Fig. 9).
Physiological Relevance of Cl2
i Block
Our observation that cytoplasmic Cl2 inhibits potently
GAT1 forward transport current raises multiple inter-
esting points. First, since the physiological Cl2 concen-
tration inside the oocyte is probably 40–50 mM (Jaffe et
al., 1985), more than threefold higher than our mea-
sured half-maximal inhibition (Fig. 10 C). The inhibi-
tory effect of Cl2
i may partially explain why the GAT1
turnover rate appears to be several times higher in our
patches, where [Cl2]i is nominally zero, than estimated
from whole cell experiments (Mager et al., 1993, 1996).443 Lu and Hilgemann
In an accompanying paper (Lu and Hilgemann, 1999),
we provide evidence that cytoplasmic Cl2 can indeed
retard a slow charge moving reaction of the transport
cycle. Second, it can be speculated that cytoplasmic Cl2
changes might provide a mechanism for shaping GABA
responses in neurons. For example, signiﬁcant Cl2
transients inside presynaptic GABA-anergic neurons
may occur during and after inhibitory post-synaptic po-
tential responses, thereby inhibiting and “deinhibiting”
GABA transport. Moreover, it has been suggested that
the cytoplasmic Cl2 concentration is regulated in indi-
vidual hippocampal neurons (Misgeld et al., 1986).
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